FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Abstract
Diabetic nephropathy (DN) is the most common cause of end‐stage renal disease. Although numerous reports have demonstrated a correlation between epithelial‐mesenchymal transition (EMT) and renal fibrosis, how these processes lead to tubular dysfunction remains unclear. Here, we show that FOXO3a protects kidneys from injury in type II DN by increasing Sirt6 expression, which deacetylates Smad3 and inhibits its transcriptional activity. The results showed that progressive EMT in the kidneys from db/db mice is associated with Sirt6 downregulation and involved in tubular injury and dysfunction. The reduction of Sirt6 levels in db/db mice resulted in progressive kidney injury, indicating the protective role of Sirt6. Furthermore, Sirt6 was shown to directly bind to Smad3, a key downstream mediator of TGF‐β, and could deacetylate it to inhibit its nuclear accumulation and transcriptional activity in HK2 cells. Besides, we demonstrate that FOXO3a activates Sirt6 expression by binding to its promoter. shRNA‐induced FOXO3a knockdown in the kidneys of db/db mice exacerbated tubular injury and renal function loss. Mechanistically, FOXO3a protects against kidney injury in type II DN through the Sirt6/Smad3 axis. Thus, the pharmacological targeting of FOXO3a‐mediated Sirt6/Smad3 signaling pathways may provide a novel strategy for treating type II DN.Keywords
Funding Information
- Health and Family Planning Commission of Sichuan Province (ZK2019B21)
This publication has 49 references indexed in Scilit:
- TGF-β1-induced epithelial–mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in Human A549 lung cancer cellsCancer Letters, 2013
- Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant MiceJournal of Biological Chemistry, 2012
- Role of the TGF-β/BMP-7/Smad pathways in renal diseasesClinical Science, 2012
- The sirtuin SIRT6 regulates lifespan in male miceNature, 2012
- The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathyCytokine & Growth Factor Reviews, 2011
- Reactive Oxygen Species Promote Caspase-12 Expression and Tubular Apoptosis in Diabetic NephropathyJournal of the American Society of Nephrology, 2010
- Diabetic nephropathy and proximal tubule ROS: Challenging our glomerulocentricityKidney International, 2007
- The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db MiceThe American Journal of Pathology, 2007
- Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6Cell, 2006
- Advanced glycation end products and the kidneyAmerican Journal of Physiology-Renal Physiology, 2005